A federal judge has indicated she is likely to dismiss Elon Musk's xAI lawsuit accusing OpenAI of stealing trade secrets, dealing a significant blow to the tech billionaire's legal offensive against his former AI venture.
Recent buying activity by multiple executives at AdNeo Limited suggests internal optimism about the company's trajectory, even as its stock trades below their purchase price.
While the small-cap index is famed for its hidden gems, some constituents face headwinds that make them less compelling for growth-focused portfolios. Here's a look at three companies analysts are currently avoiding.
Market volatility presents both risk and opportunity. We analyze two fundamentally sound yet turbulent stocks that may reward the patient, and flag one whose wild swings are best left to speculators.
Investment firm Maxim Group reaffirms its Buy rating and $1.50 price target for Strive Inc., following the company's transformative acquisition of Semler Scientific, which positions it as a major corporate Bitcoin holder and expands its healthcare tech footprint.
KeyBanc Capital Markets has upgraded LivaNova PLC (LIVN) from Sector Weight to Overweight, setting an $81 price target. The move reflects a broader positive shift in analyst sentiment towards the medical technology sector as valuation premiums ease.
Insulet Corp (PODD) has emerged as a top pick among hedge funds in the medical device sector, buoyed by overwhelmingly bullish analyst ratings and a price target suggesting significant growth potential. The company's innovative tubeless insulin pump system is seen as a key driver.
Analyst Matthew O'Brien reaffirms an Overweight rating and $420 price target for Stryker, highlighting the potential of its new Mako RPS handheld orthopedic robot to capture cost-sensitive markets and compete with rivals like Zimmer Biomet.
Eli Lilly announces a massive new manufacturing facility in Pennsylvania, part of a strategic pivot by major drugmakers to onshore production amid trade tensions and soaring demand for weight-loss drugs.
Paramount Skydance has appointed seasoned Capitol Hill and private sector strategist Ted Lehman as its top U.S. policy executive, a move signaling an intensified government relations focus as the media giant navigates a complex merger landscape and regulatory battles.
SharpLink Gaming (NASDAQ: SBET) is drawing bullish attention from major Wall Street firms, with multiple analysts reiterating Buy ratings. The company's substantial Ethereum holdings and management's crypto expertise are seen as key drivers, even as price targets adjust to market conditions.
Global spirits giant Diageo is exploring a sale of its high-profile Indian Premier League cricket franchise, Royal Challengers Bengaluru, as part of a strategic review of its Indian assets. Major private equity firms are circling, signaling strong interest in one of sports' most valuable properties.
In a bold vision outlined during Meta's earnings call, CEO Mark Zuckerberg positioned video as merely a stepping stone toward fully immersive, interactive digital experiences, powered by the convergence of AI and the mobile-first expansion of platforms like Horizon Worlds.
A routine commute in Minneapolis turns into a biometric checkpoint, spotlighting the advanced surveillance tools—from facial recognition apps to vast data networks—now central to federal immigration enforcement. As operations intensify, questions mount over privacy, oversight, and the line between targeted enforcement and dragnet surveillance.
Multiple executives and board members at AmeriServ Financial have been buying shares in the company over the past year, a move often interpreted as a bullish signal for the regional bank's prospects.
Multiple company directors at the UK hydrogen power specialist have invested heavily in its stock over the past year, a move often interpreted as a bullish signal on future prospects, despite the shares trading significantly higher now.
German industrial giant Thyssenkrupp is exploring the sale of a significant minority stake in its Rothe Erde bearings division, a move analysts say could signal a broader portfolio reshuffle and highlight persistent valuation gaps within the conglomerate.
SiTime Corporation (NASDAQ: SITM), a leader in MEMS-based timing solutions, is attracting bullish attention as its technology becomes increasingly critical for AI infrastructure and high-performance computing. With strong recent financials and strategic expansion, the company is navigating both opportunities and risks in a complex semiconductor landscape.
The Texas-born travel center giant Buc-ee's is renowned for massive stores and spotless restrooms. But its most disruptive industry practice might be its pay scale, which far exceeds typical convenience store wages and fuels intense competition for jobs.
The SEC appoints a new slate of leaders to the Public Company Accounting Oversight Board, signaling a potential shift in regulatory focus and internal dynamics as a prominent advocate for technology innovation departs.
